RECENT NEWS

The diagnostic services provider projects DermAI may decrease turnaround time for melanoma cases by 30-40%.

Grail has announced final results from the interventional Pathfinder study, which evaluated multi-cancer early detection (MCED) screening using a blood test and the clinical care pathways following a “cancer signal detected” MCED test result in 6,662 individuals aged 50 years or older, an age group at elevated risk for cancer.

Beckman Coulter Life Sciences has acquired ValitaCell, a biotechnology company that creates pioneering analytical products and technologies for the biopharmaceutical industry.

Image data from multiple hospitals improves the tool’s versatility and accuracy.

Deciphex, a leading provider of digital pathology software and services, has launched its Diagnexia service in the United States.

Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, and Nucleai, a leader in AI-powered spatial biology transforming precision medicine by unlocking the power of pathology data, hav announced a collaboration to accelerate the discovery of novel biomarkers and drug targets using the latest spatial imaging and machine learning technologies.

PhoreMost will deploy its Siteseeker platform to identify novel targets for Roche’s discovery programmes.

A laboratory service in a local hospital in West Bengal, India, is continuing to benefit from UK support offered by Mast Group and others post-COVID.

Aleiya Lonsdale, Head of Event, at Lab Innovations, explains how pharmaceutical companies in the UK can do their part to help tackle carbon emissions and reach the NHS’ net-zero goal when developing drugs.

My Pathomation's newest release focuses on promoting grassroot initiatives in digital pathology. Anybody can sign up for a free account and get involved with digital pathology this way. Users now upload and tag theirs slides, share them as public collections, or produce online course content within their own organisation.

The digital pathology platform will improve collaboration across the hospital's multi-site network and lay the foundation for unlocking new diagnostic insights with AI.

Takara Bio Europe (TBE) has announced a new partnership with the German company BioeXsen GmbH for the distribution of in vitro diagnostic solutions for the qPCR detection of common pathogens found in respiratory tract infections.

The latest version of Galen transforms diagnosis of prostate, breast and gastric cancer and includes expanded detection, user interface, and workflow integration capabilities.

The Tissue-Tek Genie provides optimal slides with the same turnaround time, using one protocol and achieving optimal staining quality across the entire 130+ Sakura antibody portfolio.

Leica Biosystems, a cancer diagnostics company and a global leader in workflow solutions, and Indica Labs, the industry-leading provider of computational and image management software in digital pathology, have announced a partnership focused on delivering compatible digital pathology workflow solutions.

Global Access Diagnostics (GADx) has acquired the manufacturing rights for the IT-LEISH rapid diagnostic test for visceral leishmaniasis from Bio-Rad, a global leader in life science research and clinical diagnostic products.

Book now for the British Association for Cytopathology (BAC) Annual Scientific Meeting (ASM) 2022, which will take place on 17 September, via Zoom.

The Microbiology Society has announced Daniel Morse (Co-founder of Show Me The Science, and lecturer at the University of Bristol) as the winner of the 2022 Microbiology in Society Award, for his engagement project ‘Show Me The Science’.

Fujifilm Europe will be attending this year’s European Congress of Pathology (ECP) where the Medical Informatics team will be showcasing Inspirata’s Dynamyx software.

Pathologists who used Ibex’s Galen Breast for cancer diagnosis obtained very high accuracy in a multi-site clinical study.